Correlation Between Franklin Biotechnology and John Hancock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and John Hancock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and John Hancock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Biotechnology Discovery and John Hancock Global, you can compare the effects of market volatilities on Franklin Biotechnology and John Hancock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of John Hancock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and John Hancock.

Diversification Opportunities for Franklin Biotechnology and John Hancock

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Franklin and John is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and John Hancock Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on John Hancock Global and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with John Hancock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of John Hancock Global has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and John Hancock go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and John Hancock

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to generate 2.31 times more return on investment than John Hancock. However, Franklin Biotechnology is 2.31 times more volatile than John Hancock Global. It trades about 0.23 of its potential returns per unit of risk. John Hancock Global is currently generating about 0.16 per unit of risk. If you would invest  12,652  in Franklin Biotechnology Discovery on June 8, 2025 and sell it today you would earn a total of  2,454  from holding Franklin Biotechnology Discovery or generate 19.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Franklin Biotechnology Discove  vs.  John Hancock Global

 Performance 
       Timeline  
Franklin Biotechnology 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Biotechnology Discovery are ranked lower than 17 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Franklin Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.
John Hancock Global 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in John Hancock Global are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, John Hancock is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Franklin Biotechnology and John Hancock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Franklin Biotechnology and John Hancock

The main advantage of trading using opposite Franklin Biotechnology and John Hancock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, John Hancock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in John Hancock will offset losses from the drop in John Hancock's long position.
The idea behind Franklin Biotechnology Discovery and John Hancock Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio